DX-8951f in Treating Women Who Have Advanced or Recurrent Cancer of the Cervix
Status:
Completed
Trial end date:
2003-09-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die.
PURPOSE: Phase II trial to study the effectiveness of DX-8951f in treating women who have
advanced or recurrent cancer of the cervix.